From the publishers of JADPRO

CAR T-Cell Therapy Resource Center

Advertisement
Fast Facts
Fast Facts #12: BCMA Targets
Fast Facts #11: Outpatient CAR T-Cell Therapy
Fast Facts #10: Viral Vectors and CAR T-Cell Therapy
Fast Facts #9: REMS Overview
Fast Facts #8: Current Commerical Products
Fast Facts #7: Interdisciplinary Team
Fast Facts #6: B-cell Aplasia and Cytopenias
Fast Facts #5: CRS/Neurotoxicity
Fast Facts #4: Manufacturing Process
Fast Facts #3: The CAR-T Patient Journey
Fast Facts #2: Immunology Basics
Fast Facts #1: Anatomy of a Chimeric Antigen Receptor
Advertisement
Case Studies

Transverse Myelitis With Paraplegia: An Atypical Manifestation of Neurotoxicity Following CAR T-Cell Therapy

CAR T-cell Infusion in an Outpatient Setting: An Ideal Option for Selected Patients When Available

B-Cell Aplasia, Hypogammaglobulinemia Can Result in Serious, Life-Threatening Infections

Fast Facts

Fast Facts #12: BCMA Targets

Advertisement
Quizzes
Test your knowledge of atypical manifestation of neurotoxicity following CAR T-cell therapy
Test your knowledge of CAR T-cell therapy
Test your knowledge of CAR T-cell infusion in an outpatient setting